NCT05400876 2023-02-14To Evaluate the Safety and Efficacy of TQB2618 Injection Combined With Penpulimab in the Treatment of Patients With Relapsed and Refractory LymphomaChia Tai Tianqing Pharmaceutical Group Co., Ltd.Phase 1/2 Unknown92 enrolled